1. Home
  2. ANVS vs ALTS Comparison

ANVS vs ALTS Comparison

Compare ANVS & ALTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • ALTS
  • Stock Information
  • Founded
  • ANVS 2008
  • ALTS 1976
  • Country
  • ANVS United States
  • ALTS United States
  • Employees
  • ANVS N/A
  • ALTS N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • ALTS
  • Sector
  • ANVS Health Care
  • ALTS
  • Exchange
  • ANVS Nasdaq
  • ALTS NYSE
  • Market Cap
  • ANVS 92.6M
  • ALTS 72.7M
  • IPO Year
  • ANVS 2020
  • ALTS N/A
  • Fundamental
  • Price
  • ANVS $2.73
  • ALTS $6.90
  • Analyst Decision
  • ANVS Strong Buy
  • ALTS
  • Analyst Count
  • ANVS 6
  • ALTS 0
  • Target Price
  • ANVS $31.40
  • ALTS N/A
  • AVG Volume (30 Days)
  • ANVS 621.3K
  • ALTS 244.7K
  • Earning Date
  • ANVS 03-31-2025
  • ALTS 04-07-2025
  • Dividend Yield
  • ANVS N/A
  • ALTS N/A
  • EPS Growth
  • ANVS N/A
  • ALTS N/A
  • EPS
  • ANVS N/A
  • ALTS N/A
  • Revenue
  • ANVS N/A
  • ALTS $7,110,000.00
  • Revenue This Year
  • ANVS N/A
  • ALTS N/A
  • Revenue Next Year
  • ANVS N/A
  • ALTS N/A
  • P/E Ratio
  • ANVS N/A
  • ALTS N/A
  • Revenue Growth
  • ANVS N/A
  • ALTS N/A
  • 52 Week Low
  • ANVS $2.44
  • ALTS $0.78
  • 52 Week High
  • ANVS $20.00
  • ALTS $7.09
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 23.71
  • ALTS 62.80
  • Support Level
  • ANVS $2.44
  • ALTS $4.60
  • Resistance Level
  • ANVS $5.50
  • ALTS $6.64
  • Average True Range (ATR)
  • ANVS 0.31
  • ALTS 0.65
  • MACD
  • ANVS -0.11
  • ALTS 0.02
  • Stochastic Oscillator
  • ANVS 11.28
  • ALTS 98.29

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.

About ALTS ALT5 SIGMA CORPORATION

ALT5 Sigma Corp is a fintech company. It is providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment and safe-keeping of digital assets. The company product include ALT 5 Prime is an electronic over-the-counter trading platform and ALT 5 Pay crypto payment processor.

Share on Social Networks: